Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol
CA 2461085 A1 · Owner: Lipton, Allan · Inventors: Green, Jonathan; Lipton, Allan; Witters, Lois Mary
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A pharmaceutical composition for treatment of malignancies in particular a , malignant disease which is associated with the development of bone metastases or excessive bone resorption, comprises in combination a bisphosphonates COX-, 2 inhibitor and/or a taxol or derivative thereof for simultaneous sequential , or separate use. Also provided is a method of treating a patient suffering from a malignant disease comprising administering to the patient an effective amount of a bisphosphonates, an effective amount of a COX-2 inhibitor and/or and effective amount of a taxol or derivative thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 18, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 18, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 18, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.